PDS Biotechnology Corporation

PDSB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$41,690$56,561$73,820$65,243
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,365$2,495$2,660$1,598
Total Curr. Assets$45,054$59,055$76,480$66,840
Property Plant & Equip (Net)$304$335$528$358
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$304$335$528$358
Other Assets$0$0$0$0
Total Assets$45,359$59,390$77,008$67,198
Liabilities
Payables$1,685$6,983$1,219$1,309
Short-Term Debt$12,561$4,222$288$259
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,841$2,425$8,314$2,188
Total Curr. Liab.$17,087$13,630$9,821$3,756
LT Debt$9,267$19,629$23,185$231
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$9,267$19,629$23,185$231
Other Liabilities$0$0$0$0
Cap. Leases$123$179$452$490
Total Liabilities$26,354$33,259$33,006$3,987
Equity
Pref Stock$0$0$0$0
Common Stock$13$11$10$9
Retained Earnings-$182,111-$144,501-$101,558-$60,704
AOCI$0$0$0$0
Other Equity$201,103$170,621$145,550$123,905
Total Equity$19,005$26,131$44,002$63,210
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$45,359$59,390$77,008$67,198
Net Debt-$19,862-$32,709-$50,347-$64,752